nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—melanoma	0.627	1	CbGaD
Phenylbutazone—CYP3A4—Temozolomide—melanoma	0.0398	0.576	CbGbCtD
Phenylbutazone—CYP3A4—Vemurafenib—melanoma	0.0218	0.316	CbGbCtD
Phenylbutazone—PTGIS—endothelium—melanoma	0.0174	0.162	CbGeAlD
Phenylbutazone—PTGIS—blood vessel—melanoma	0.0161	0.149	CbGeAlD
Phenylbutazone—SLC22A8—optic choroid—melanoma	0.0134	0.125	CbGeAlD
Phenylbutazone—Clobazam—SLC6A11—melanoma	0.00753	0.659	CrCbGaD
Phenylbutazone—CYP3A4—Docetaxel—melanoma	0.00748	0.108	CbGbCtD
Phenylbutazone—PTGIS—mammalian vulva—melanoma	0.00678	0.063	CbGeAlD
Phenylbutazone—PTGS2—leg—melanoma	0.00675	0.0626	CbGeAlD
Phenylbutazone—PTGS2—hindlimb—melanoma	0.00602	0.0559	CbGeAlD
Phenylbutazone—PTGS2—appendage—melanoma	0.00517	0.048	CbGeAlD
Phenylbutazone—PTGIS—head—melanoma	0.00485	0.0451	CbGeAlD
Phenylbutazone—PTGS2—skin epidermis—melanoma	0.0043	0.0399	CbGeAlD
Phenylbutazone—PTGIS—lymph node—melanoma	0.0034	0.0316	CbGeAlD
Phenylbutazone—PTGS1—endothelium—melanoma	0.00326	0.0303	CbGeAlD
Phenylbutazone—PTGS2—endothelium—melanoma	0.00312	0.029	CbGeAlD
Phenylbutazone—PTGS1—blood vessel—melanoma	0.00301	0.0279	CbGeAlD
Phenylbutazone—PTGS2—blood vessel—melanoma	0.00288	0.0267	CbGeAlD
Phenylbutazone—SLC22A8—eye—melanoma	0.0027	0.0251	CbGeAlD
Phenylbutazone—SLC22A8—head—melanoma	0.00153	0.0142	CbGeAlD
Phenylbutazone—PTGS1—skin of body—melanoma	0.00139	0.0129	CbGeAlD
Phenylbutazone—PTGS2—skin of body—melanoma	0.00133	0.0124	CbGeAlD
Phenylbutazone—PTGS1—mammalian vulva—melanoma	0.00127	0.0118	CbGeAlD
Phenylbutazone—PTGS1—head—melanoma	0.000909	0.00844	CbGeAlD
Phenylbutazone—PTGS2—head—melanoma	0.000869	0.00807	CbGeAlD
Phenylbutazone—PTGS1—lymph node—melanoma	0.000637	0.00591	CbGeAlD
Phenylbutazone—Oxaprozin—PTGS2—melanoma	0.000632	0.0553	CrCbGaD
Phenylbutazone—PTGS2—lymph node—melanoma	0.000609	0.00565	CbGeAlD
Phenylbutazone—Fosphenytoin—ALB—melanoma	0.000586	0.0512	CrCbGaD
Phenylbutazone—Protriptyline—ABCB1—melanoma	0.000546	0.0477	CrCbGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—melanoma	0.000499	0.0437	CrCbGaD
Phenylbutazone—Phenprocoumon—ALB—melanoma	0.000401	0.0351	CrCbGaD
Phenylbutazone—Fentanyl—ABCB1—melanoma	0.000272	0.0238	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—melanoma	0.000271	0.0237	CrCbGaD
Phenylbutazone—Phenytoin—ALB—melanoma	0.000259	0.0226	CrCbGaD
Phenylbutazone—Phenytoin—ABCB1—melanoma	0.000247	0.0216	CrCbGaD
Phenylbutazone—Methadone—ABCB1—melanoma	0.000187	0.0163	CrCbGaD
Phenylbutazone—PTGS2—Metabolism—MTAP—melanoma	6.9e-05	0.000374	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.89e-05	0.000374	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MDM2—melanoma	6.87e-05	0.000373	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CSPG4—melanoma	6.83e-05	0.00037	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB2—melanoma	6.77e-05	0.000367	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.76e-05	0.000366	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.74e-05	0.000366	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RPS3—melanoma	6.72e-05	0.000364	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CB—melanoma	6.68e-05	0.000363	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD4—melanoma	6.67e-05	0.000362	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—melanoma	6.62e-05	0.000359	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SKI—melanoma	6.61e-05	0.000359	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HS3ST5—melanoma	6.59e-05	0.000358	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.58e-05	0.000357	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.51e-05	0.000353	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CD—melanoma	6.42e-05	0.000348	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—melanoma	6.37e-05	0.000345	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	6.36e-05	0.000345	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	6.35e-05	0.000344	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ALB—melanoma	6.34e-05	0.000344	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.32e-05	0.000343	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1B—melanoma	6.27e-05	0.00034	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	6.16e-05	0.000334	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LUM—melanoma	6.15e-05	0.000334	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PHGDH—melanoma	6.15e-05	0.000334	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HPSE—melanoma	6.03e-05	0.000327	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PLA2G6—melanoma	5.93e-05	0.000322	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—melanoma	5.93e-05	0.000321	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CUBN—melanoma	5.92e-05	0.000321	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—melanoma	5.83e-05	0.000316	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1A—melanoma	5.79e-05	0.000314	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTEN—melanoma	5.78e-05	0.000313	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.73e-05	0.000311	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SDHD—melanoma	5.72e-05	0.00031	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CSPG4—melanoma	5.72e-05	0.00031	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BSG—melanoma	5.72e-05	0.00031	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CB—melanoma	5.6e-05	0.000304	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—melanoma	5.55e-05	0.000301	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPAM—melanoma	5.54e-05	0.0003	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HDAC6—melanoma	5.46e-05	0.000296	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.42e-05	0.000294	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—VCAN—melanoma	5.33e-05	0.000289	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.31e-05	0.000288	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.27e-05	0.000286	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NPPA—melanoma	5.17e-05	0.000281	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—melanoma	5.17e-05	0.00028	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.16e-05	0.00028	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.16e-05	0.00028	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NRAS—melanoma	5.15e-05	0.000279	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	5.14e-05	0.000279	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACER3—melanoma	5.11e-05	0.000277	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—VCAN—melanoma	5.05e-05	0.000274	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.04e-05	0.000273	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—WNT5A—melanoma	5.01e-05	0.000272	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLCB4—melanoma	5e-05	0.000271	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK3—melanoma	4.94e-05	0.000268	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.91e-05	0.000266	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	4.9e-05	0.000266	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.87e-05	0.000264	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.87e-05	0.000264	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTEN—melanoma	4.84e-05	0.000262	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—melanoma	4.8e-05	0.00026	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PLA2G6—melanoma	4.71e-05	0.000255	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIP4K2A—melanoma	4.7e-05	0.000255	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC6A11—melanoma	4.7e-05	0.000255	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK1—melanoma	4.7e-05	0.000255	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—melanoma	4.7e-05	0.000255	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UGT2B10—melanoma	4.68e-05	0.000254	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTAP—melanoma	4.57e-05	0.000248	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP17A1—melanoma	4.49e-05	0.000244	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.48e-05	0.000243	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.47e-05	0.000242	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—melanoma	4.44e-05	0.000241	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.43e-05	0.00024	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	4.38e-05	0.000237	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HS3ST5—melanoma	4.35e-05	0.000236	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.33e-05	0.000235	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GNA11—melanoma	4.24e-05	0.00023	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—VCAN—melanoma	4.23e-05	0.000229	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—FASN—melanoma	4.15e-05	0.000225	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC5A5—melanoma	4.09e-05	0.000222	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—melanoma	4.07e-05	0.000221	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LUM—melanoma	4.07e-05	0.000221	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PHGDH—melanoma	4.07e-05	0.000221	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GAB2—melanoma	4.02e-05	0.000218	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4e-05	0.000217	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HPSE—melanoma	3.99e-05	0.000217	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD44—melanoma	3.95e-05	0.000214	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GNAQ—melanoma	3.95e-05	0.000214	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FASN—melanoma	3.94e-05	0.000214	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CUBN—melanoma	3.92e-05	0.000213	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.86e-05	0.00021	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.86e-05	0.00021	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.83e-05	0.000208	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BSG—melanoma	3.79e-05	0.000205	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SDHD—melanoma	3.79e-05	0.000205	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CSPG4—melanoma	3.79e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP1B1—melanoma	3.78e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CXCR4—melanoma	3.78e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HDAC2—melanoma	3.78e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FOXO4—melanoma	3.78e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HRAS—melanoma	3.77e-05	0.000204	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD44—melanoma	3.74e-05	0.000203	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPAM—melanoma	3.67e-05	0.000199	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.66e-05	0.000198	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—melanoma	3.61e-05	0.000196	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP17A1—melanoma	3.57e-05	0.000194	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.52e-05	0.000191	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.47e-05	0.000188	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT3—melanoma	3.45e-05	0.000187	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—melanoma	3.41e-05	0.000185	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GNA11—melanoma	3.37e-05	0.000183	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.34e-05	0.000181	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—melanoma	3.33e-05	0.000181	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FASN—melanoma	3.3e-05	0.000179	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLCB4—melanoma	3.29e-05	0.000179	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC5A5—melanoma	3.24e-05	0.000176	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD44—melanoma	3.13e-05	0.00017	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GNAQ—melanoma	3.13e-05	0.00017	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLA2G6—melanoma	3.12e-05	0.000169	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—melanoma	3.12e-05	0.000169	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC6A11—melanoma	3.1e-05	0.000168	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIP4K2A—melanoma	3.1e-05	0.000168	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.07e-05	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB4—melanoma	3.05e-05	0.000165	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—melanoma	3.02e-05	0.000164	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTAP—melanoma	3.01e-05	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1B1—melanoma	3e-05	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD86—melanoma	2.92e-05	0.000159	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PRKCA—melanoma	2.87e-05	0.000155	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ERCC2—melanoma	2.84e-05	0.000154	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF1—melanoma	2.83e-05	0.000154	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—VCAN—melanoma	2.8e-05	0.000152	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—melanoma	2.79e-05	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFRA—melanoma	2.75e-05	0.000149	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCA—melanoma	2.72e-05	0.000147	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERCC2—melanoma	2.7e-05	0.000146	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LUM—melanoma	2.69e-05	0.000146	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PHGDH—melanoma	2.69e-05	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAP2K2—melanoma	2.66e-05	0.000144	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.65e-05	0.000144	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.65e-05	0.000144	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HPSE—melanoma	2.63e-05	0.000143	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CUBN—melanoma	2.59e-05	0.00014	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.56e-05	0.000139	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TERT—melanoma	2.53e-05	0.000137	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HLA-A—melanoma	2.53e-05	0.000137	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RAC1—melanoma	2.52e-05	0.000137	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BSG—melanoma	2.5e-05	0.000135	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SDHD—melanoma	2.5e-05	0.000135	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CSPG4—melanoma	2.5e-05	0.000135	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—melanoma	2.47e-05	0.000134	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPAM—melanoma	2.42e-05	0.000131	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIF1A—melanoma	2.42e-05	0.000131	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP17A1—melanoma	2.36e-05	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.36e-05	0.000128	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.33e-05	0.000126	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.3e-05	0.000125	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PRKCA—melanoma	2.28e-05	0.000123	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ERCC2—melanoma	2.26e-05	0.000122	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—melanoma	2.25e-05	0.000122	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GNA11—melanoma	2.23e-05	0.000121	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—melanoma	2.2e-05	0.000119	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FASN—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOTCH1—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—melanoma	2.17e-05	0.000118	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC5A5—melanoma	2.15e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD80—melanoma	2.13e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KIT—melanoma	2.13e-05	0.000115	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—melanoma	2.13e-05	0.000115	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGF—melanoma	2.1e-05	0.000114	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GNAQ—melanoma	2.07e-05	0.000113	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD44—melanoma	2.07e-05	0.000113	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLA2G6—melanoma	2.06e-05	0.000112	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.03e-05	0.00011	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.01e-05	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BRAF—melanoma	2e-05	0.000109	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1B1—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CD—melanoma	1.97e-05	0.000107	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—melanoma	1.95e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAP2K1—melanoma	1.88e-05	0.000102	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CD—melanoma	1.87e-05	0.000101	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.87e-05	0.000101	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—VCAN—melanoma	1.85e-05	0.0001	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—melanoma	1.79e-05	9.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—melanoma	1.78e-05	9.67e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.76e-05	9.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CB—melanoma	1.72e-05	9.33e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—melanoma	1.72e-05	9.33e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—melanoma	1.7e-05	9.25e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MDM2—melanoma	1.68e-05	9.09e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—melanoma	1.65e-05	8.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—melanoma	1.64e-05	8.88e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CB—melanoma	1.63e-05	8.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—melanoma	1.63e-05	8.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CD—melanoma	1.57e-05	8.5e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP17A1—melanoma	1.56e-05	8.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—melanoma	1.55e-05	8.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—melanoma	1.53e-05	8.3e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PRKCA—melanoma	1.51e-05	8.17e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ERCC2—melanoma	1.49e-05	8.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—melanoma	1.49e-05	8.06e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GNA11—melanoma	1.47e-05	7.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—melanoma	1.45e-05	7.84e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FASN—melanoma	1.44e-05	7.81e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A5—melanoma	1.42e-05	7.68e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1A—melanoma	1.41e-05	7.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—melanoma	1.41e-05	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GNAQ—melanoma	1.37e-05	7.42e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD44—melanoma	1.37e-05	7.42e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CB—melanoma	1.37e-05	7.41e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1B1—melanoma	1.31e-05	7.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—melanoma	1.26e-05	6.84e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NRAS—melanoma	1.26e-05	6.82e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.24e-05	6.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK3—melanoma	1.2e-05	6.53e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—melanoma	1.18e-05	6.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—melanoma	1.18e-05	6.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—melanoma	1.17e-05	6.35e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK1—melanoma	1.15e-05	6.21e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—melanoma	1.15e-05	6.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—melanoma	1.14e-05	6.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—melanoma	1.08e-05	5.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—melanoma	1.08e-05	5.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—melanoma	1.05e-05	5.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CD—melanoma	1.04e-05	5.63e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—melanoma	1.02e-05	5.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—melanoma	9.94e-06	5.39e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PRKCA—melanoma	9.94e-06	5.39e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ERCC2—melanoma	9.86e-06	5.35e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HRAS—melanoma	9.2e-06	4.99e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CB—melanoma	9.05e-06	4.91e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—melanoma	8.96e-06	4.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—melanoma	8.8e-06	4.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—melanoma	8.57e-06	4.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—melanoma	8.33e-06	4.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—melanoma	8.12e-06	4.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—melanoma	7.82e-06	4.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—melanoma	7.79e-06	4.22e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—melanoma	7.51e-06	4.08e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CD—melanoma	6.84e-06	3.71e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—melanoma	6.8e-06	3.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—melanoma	6.76e-06	3.66e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CB—melanoma	5.97e-06	3.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—melanoma	5.91e-06	3.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—melanoma	5.51e-06	2.99e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—melanoma	5.16e-06	2.8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—melanoma	4.5e-06	2.44e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—melanoma	3.64e-06	1.97e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—melanoma	2.97e-06	1.61e-05	CbGpPWpGaD
